New scan aims to spot hidden brain cancer recurrence
NCT ID NCT06777433
Summary
This study is testing a new imaging agent called RAD101 for PET scans. The goal is to see if it can better identify when brain tumors from common cancers like lung or breast cancer have returned after previous radiation treatment. About 30 adults who are suspected of having recurrent brain metastases will receive one dose of RAD101 and undergo specialized scans to compare its accuracy to standard MRI.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES FROM SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ascension Illinois Oncology Research
RECRUITINGHoffman Estates, Illinois, 60169, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
BAMF Health
RECRUITINGGrand Rapids, Michigan, 49503, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Goshen Center for Cancer Care
RECRUITINGGoshen, Indiana, 46526, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.